LBA80 Siremadlin (S) and ribociclib (R) in patients (pt) with advanced well-differentiated/dedifferentiated liposarcomas (WD/DD LPS) and other molecularly selected cancers: Final analysis of the MEGAMOST "Ribociclib/HDM201" basket study. - Brahmi, M.; Tredan, O.; Gomez-Roca, C.A.; Italiano, A.; Saada, E.B.; Bertucci, F.; Le Cesne, A.; Cassier, P.; Treilleux, I.; Chabaud, S.; Fournier Garin, G.; Perol, D.; et al. (Annals of Oncology, 2024)